2020 1st semester turnover and prospects - Seite 3

Thanks to a comfortable cash position, an international footprint, well-known innovative product lines and solid partnerships, Spineway will be able to benefit from the return to activity in the various areas in which it does business and take advantage of opportunities for external growth that could offer great synergies.

SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com

Upcoming: 27 October 2020 – 2020 half-year results

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.

Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).

ISIN: FR0011398874 - ALSPW

Contacts:

SPINEWAY Shareholder-services line Available Tuesday through Thursday (10 a.m. – 12 p.m.) [phone]

Eligible PEA / PME ALSPW Euronext Growth

AELIUM Finance & Communication Investor relations Solène Kennis [e-mail]

Attachment

• SPW_CP_CA_S12020_VD_GB